55 related articles for article (PubMed ID: 19019480)
1. EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.
Schuster C; Baumert TF
J Hepatol; 2009 Jan; 50(1):222-4. PubMed ID: 19019480
[TBL] [Abstract][Full Text] [Related]
2. The CD81 partner EWI-2wint inhibits hepatitis C virus entry.
Rocha-Perugini V; Montpellier C; Delgrange D; Wychowski C; Helle F; Pillez A; Drobecq H; Le Naour F; Charrin S; Levy S; Rubinstein E; Dubuisson J; Cocquerel L
PLoS One; 2008 Apr; 3(4):e1866. PubMed ID: 18382656
[TBL] [Abstract][Full Text] [Related]
3. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection.
Montpellier C; Tews BA; Poitrimole J; Rocha-Perugini V; D'Arienzo V; Potel J; Zhang XA; Rubinstein E; Dubuisson J; Cocquerel L
J Biol Chem; 2011 Apr; 286(16):13954-65. PubMed ID: 21343309
[TBL] [Abstract][Full Text] [Related]
4. EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.
Potel J; Rassam P; Montpellier C; Kaestner L; Werkmeister E; Tews BA; Couturier C; Popescu CI; Baumert TF; Rubinstein E; Dubuisson J; Milhiet PE; Cocquerel L
Cell Microbiol; 2013 Jul; 15(7):1234-52. PubMed ID: 23351194
[TBL] [Abstract][Full Text] [Related]
5. Early steps of the hepatitis C virus life cycle.
Dubuisson J; Helle F; Cocquerel L
Cell Microbiol; 2008 Apr; 10(4):821-7. PubMed ID: 18081727
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
Perrault M; Pécheur EI
Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
[TBL] [Abstract][Full Text] [Related]
7. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.
Charrin S; Le Naour F; Labas V; Billard M; Le Caer JP; Emile JF; Petit MA; Boucheix C; Rubinstein E
Biochem J; 2003 Jul; 373(Pt 2):409-21. PubMed ID: 12708969
[TBL] [Abstract][Full Text] [Related]
8. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.
Voisset C; Lavie M; Helle F; Op De Beeck A; Bilheu A; Bertrand-Michel J; Tercé F; Cocquerel L; Wychowski C; Vu-Dac N; Dubuisson J
Cell Microbiol; 2008 Mar; 10(3):606-17. PubMed ID: 17979982
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus entry: role of host and viral factors.
Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
[TBL] [Abstract][Full Text] [Related]
10. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus entry into host cells.
Helle F; Dubuisson J
Cell Mol Life Sci; 2008 Jan; 65(1):100-12. PubMed ID: 17914604
[TBL] [Abstract][Full Text] [Related]
13. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
14. Visualizing hepatitis C virus infections in human liver by two-photon microscopy.
Liang Y; Shilagard T; Xiao SY; Snyder N; Lau D; Cicalese L; Weiss H; Vargas G; Lemon SM
Gastroenterology; 2009 Oct; 137(4):1448-58. PubMed ID: 19632233
[TBL] [Abstract][Full Text] [Related]
15. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
Régeard M; Trotard M; Lepère C; Gripon P; Le Seyec J
J Viral Hepat; 2008 Dec; 15(12):865-70. PubMed ID: 19087225
[TBL] [Abstract][Full Text] [Related]
16. Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection.
Coquillard G; Patterson BK
J Infect Dis; 2009 Sep; 200(6):947-54. PubMed ID: 19678757
[TBL] [Abstract][Full Text] [Related]
17. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
18. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
19. Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation.
Ito M; Sun S; Fukuhara T; Suzuki R; Tamai M; Yamauchi T; Nakashima K; Tagawa YI; Okazaki S; Matsuura Y; Wakita T; Suzuki T
Oncotarget; 2017 Aug; 8(33):53899-53915. PubMed ID: 28903311
[TBL] [Abstract][Full Text] [Related]
20. [Entry of HCV into target cells].
Helle F; Cocquerel L
Virologie (Montrouge); 2008 Apr; 12(2):105-116. PubMed ID: 36131420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
